About this episode

Dr. Boon Chong Goh discusses his journey in developing precision microbiome solutions and the transition from academia to entrepreneurship.

Dr. Boon Chong Goh is the co-founder and CTO of ArrowBiome , a Singapore-based biotech startup developing precision microbiome solutions through its lysin engineering platform. Spun out from the Singapore-MIT Alliance for Research and Technology and NTU Lee Kong Chian School of Medicine, ArrowBiome develops proprietary and patented platform technologies that enable highly selective bacterial targeting and killing. With “arrow-like” precision, the company is advancing microbiome solutions across applications including body odour, acne, other bacteria-associated skin conditions, gut health, and antimicrobial resistance. In this episode, Boon Chong shares how his journey from physics, protein structure, and molecular simulations led him into antimicrobial resistance research and eventually entrepreneurship. He discusses why lysins are powerful tools for precision microbiome control, how ArrowBiome moved from academic research to commercialization, and why the company strategically entered skincare and personal care before tackling more complex antimicrobial challenges. He also reflects on startup fundraising, Singapore’s biotech ecosystem, scaling production, global expansion, and…

Explore listener stats, chart rankings, contacts and more on the Nucleate Singapore Pulse podcast page.